(Q50862894)
Statements
1 reference
Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials. (English)
1 reference
M V Dieci
A Frassoldati
D Generali
G Bisagni
F Piacentini
L Cavanna
K Cagossi
A Michelotti
R Berardi
G Banna
A Goubar
3 April 2017
1 reference